Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomized Evaluation of Single Agent GA101 Versus GA101 Plus Bendamustine Followed by GA101

NCT03492775 is registered in ClinicalTrials.gov with Prof. Dr. Wolfgang Hiddemann as lead sponsor.

NCT NCT03492775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03492775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomized Evaluation of Single Agent GA101 Versus GA101 Plus Bendamustine Followed by GA101
Lead sponsor
Prof. Dr. Wolfgang Hiddemann
Phase
Phase 2
Overall status
Completed
Start date
December 12, 2017
Completion date
December 31, 2022
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

indolent non-hodgkin lymphoma